Last updated: April 28, 2026
Sponsor: University Hospital, Grenoble
Overall Status: Completed
Phase
N/A
Condition
Allergies & Asthma
Allergy
Urticaria
Treatment
N/AClinical Study ID
NCT06806618
3824.0394
Ages > 12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
For the patient population:
Patients with a confirmed diagnosis of HAE with a deficit in the C1 inhibitor.
Aged ≥12 years
Having consulted for HAE in the last 3 months and with a medical file.
For the caregiver population:
- A person identified by the patient as part of their support group and who provides support with the management of the patients HAE (including family members, friends, spouse, etc.)
Exclusion
Exclusion Criteria:
For the patient population:
Opposes to participating in the study.
Patients is under guardianship or deprived of their liberty.
Study Design
Total Participants: 300
Study Start date:
March 01, 2025
Estimated Completion Date:
August 29, 2025
Study Description
Connect with a study center
CHU Grenoble Alpes
Grenoble,
FranceSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.